Log in to your Inderes Free account to see all free content on this page.

Medivir

1.89 SEK

-7.13%

Less than 1K followers

MVIR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue1.03.50.61.50.95.58.51.0
EBITDA-26.2-124.6-12.6-22.5-12.9-12.0-60.1-8.8
EBIT-26.9-127.3-13.3-23.2-13.6-42.5-92.6-9.4
EBIT-%-2,690.0 %-3,637.1 %-2,216.7 %-1,546.7 %-1,511.1 %-772.7 %-1,089.4 %-940.0 %
Profit before taxes-26.7-123.3-13.3-23.3-14.6-43.2-94.4-9.4
Net income-26.7-123.3-13.3-23.3-14.6-43.2-94.4-9.4
Login required

This content is only available for logged in users